Slowing down glioblastoma progression in mice by running or the anti-malarial drug dihydroartemisinin?: induction of oxidative stress in murine glioblastoma therapy

https://doi.org/10.18632/oncotarget.10723 Dieter Lemke, Hans-Werner Pledl, Markus Zorn, Manfred Jugold, Ed Green, Jonas Blaes, Sarah Löw, Anne Hertenstein, Martina Ott, Felix Sahm, Ann-Catherine...

Bibliographic Details

Main Authors:	Lemke, Dieter (Author) , Pledl, Hans-Werner (Author) , Zorn, Markus (Author) , Jugold, Manfred (Author) , Green, Ed (Author) , Blaes, Jonas (Author) , Löw, Sarah (Author) , Hertenstein, Anne (Author) , Ott, Martina (Author) , Sahm, Felix (Author) , Steffen, Ann-Catherine (Author) , Weiler, Markus (Author) , Winkler, Frank (Author) , Platten, Michael (Author) , Dong, Zhen (Author) , Wick, Wolfgang (Author)
Format:	Article (Journal)
Language:	English
Published:	July 20, 2016
In:	OncoTarget Year: 2016, Volume: 7, Issue: 35, Pages: 56713-56725
ISSN:	1949-2553
DOI:	10.18632/oncotarget.10723
Online Access:	Verlag, lizenzpflichtig, Volltext: https://doi.org/10.18632/oncotarget.10723 Verlag, lizenzpflichtig, Volltext: https://www.oncotarget.com/article/10723/text/
Author Notes:	Dieter Lemke, Hans-Werner Pledl, Markus Zorn, Manfred Jugold, Ed Green, Jonas Blaes, Sarah Löw, Anne Hertenstein, Martina Ott, Felix Sahm, Ann-Catherine Steffen, Markus Weiler, Frank Winkler, Michael Platten, Zhen Dong, Wolfgang Wick